Immunity through DNA deamination

Trends in Biochemical Sciences

Volumn 28, Issue 6, 2003, Pages 305-312

  Neuberger, Michael S ^a   Harris, Reuben S ^a   Di Noia, Javier ^a   Petersen Mahrt, Svend K ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DEAMINASE; DNA; IMMUNOGLOBULIN; NUCLEIC ACID;

CARCINOMA; DEAMINATION; ENZYME ACTIVITY; EVOLUTION; GENE CONVERSION; GENE REARRANGEMENT; GENETIC VARIABILITY; GENOME; IMMUNE SYSTEM; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC HYPERMUTATION;

EID: 0038713344     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(03)00111-7     Document Type: Review

References (62)

1. Lindahl T. An N-glycosidase from Escherichia coli that releases free uracil from DNA containing deaminated cytosine residues. Proc. Natl. Acad. Sci. U. S. A. 71:1974;3649-3653.
2. Nilsen H., Krokan H.E. Base excision repair in a network of defence and tolerance. Carcinogenesis. 22:2001;987-998.
3. Muramatsu M., et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274:1999;18470-18476.
4. Petersen-Mahrt S.K., et al. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature. 418:2002;99-104.
5. Di Noia J., Neuberger M.S. Altering the pathway of Ig V gene hypermutation by inhibiting uracil DNA glycosylase. Nature. 419:2002;43-48.
6. Rada C., et al. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12:2002;1748-1755.
7. Tonegawa S. Somatic generation of antibody diversity. Nature. 302:1983;575-581.
8. Schatz D.G., et al. The V(D)J recombination activating gene, RAG-1. Cell. 59:1989;1035-1048.
9. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71:2002;101-132.
10. Reynaud C.A., et al. Formation of the chicken B-cell repertoire: ontogenesis, regulation of Ig gene rearrangement, and diversification by gene conversion. Adv. Immunol. 57:1994;353-378.
11. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 381:1996;751-758.
12. Manis J.P., et al. Mechanism and control of class-switch recombination. Trends Immunol. 23:2002;31-39.
13. Muramatsu M., et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:2000;553-563.
14. Revy P., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 102:2000;565-575.
15. Arakawa H., et al. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science. 295:2002;1301-1306.
16. Harris R.S., et al. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12:2002;435-438.
17. Sale J.E., et al. Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature. 412:2001;921-926.
18. Maizels N. Somatic hypermutation: how many mechanisms diversify V region sequences? Cell. 83:1995;9-12.
19. Weill J.C., Reynaud C.A. Rearrangement-hypermutation-gene conversion: when, where and why? Immunol. Today. 17:1996;92-97.
20. Ehrenstein M.R., Neuberger M.S. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 18:1999;3484-3490.
21. Neuberger M.S., et al. Antibody diversification and selection in the mature B-cell compartment. Cold Spring Harb. Symp. Quant. Biol. 64:1999;211-216.
22. Neuberger M.S., et al. Memory in the B-cell compartment: antibody affinity maturation. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:2000;357-360.
23. Martin A., et al. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature. 415:2002;802-806.
24. Okazaki I., et al. The AID enzyme induces class switch recombination in fibroblasts. Nature. 416:2002;340-345.
25. Powell L.M., et al. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine. Cell. 50:1987;831-840.
26. Teng B., et al. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science. 260:1993;1816-1819.
27. Rada C., et al. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity. 9:1998;135-141.
28. Wiesendanger M., et al. Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J. Exp. Med. 191:2000;579-584.
29. Zeng X., et al. DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immun. 2:2001;537-541.
30. Harris R.S., et al. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell. 10:2002;1247-1253.
31. Nilsen H., et al. Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol. Cell. 5:2000;1059-1065.
32. Madsen P. Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J. Invest. Dermatol. 113:1999;162-169.
33. Anant S., et al. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. Am. J. Physiol. Cell Physiol. 281:2001;C1904-C1916.
34. Jarmuz A., et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 79:2002;285-296.
35. Navaratnam N., et al. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition. J. Mol. Biol. 275:1998;695-714.
36. Blanc V., Davidson N.O. C-to-U RNA editing: mechanisms leading to genetic diversity. J. Biol. Chem. 278:2003;1395-1398.
37. Lellek H., et al. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J. Biol. Chem. 275:2000;19848-19856.
38. Mehta A., et al. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20:2000;1846-1854.
39. Migliazza A., et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 92:1995;12520-12524.
40. Pasqualucci L., et al. R. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. U. S. A. 95:1998;11816-11821.
41. Shen H.M., et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 280:1998;1750-1752.
42. Pasqualucci L., et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 412:2001;341-346.
43. Sheehy A.M., et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 418:2002;646-650.
44. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 71:2002;817-846.
45. Selker E.U. Premeiotic instability of repeated sequences in Neurospora crassa. Annu. Rev. Genet. 24:1990;579-613.
46. Freitag M., et al. A cytosine methyltransferase homologue is essential for repeat-induced point mutation in Neurospora crassa. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8802-8807.
47. Shen J.-C., et al. High frequency mutagenesis by a DNA methyltransferase. Cell. 71:1992;1073-1080.
48. Yebra M.J., Bhagwat A.S. A cytosine methyltransferase converts 5-methylcytosine in DNA to thymine. Biochemistry. 34:1995;14752-14757.
49. Macintyre G., et al. Lowering S-adenosylmethionine levels in Escherichia coli modulates C-to-T transition mutations. J. Bacteriol. 183:2001;921-927.
50. Lindahl T. Instability and decay of the primary structure of DNA. Nature. 362:1993;709-715.
51. Rabbitts T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
52. Kuppers R., Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 20:2001;5580-5594.
53. Yamanaka S., et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. U. S. A. 92:1995;8483-8487.
54. Takahashi L., Marmur J. Replacement of thymidylic acid by deoxyuridylic acid in the deoxyribonucleic acid of a transducing phage for Bacillus subtilis. Nature. 197:1963;794-795.
55. Casellas R., et al. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17:1998;2404-2411.
56. Manis J.P., et al. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J. Exp. Med. 187:1998;2081-2089.
57. Gerber A.P., Keller W. RNA editing by base deamination: more enzymes, more targets, new mysteries. Trends Biochem. Sci. 26:2001;376-384.
58. Betts L., et al. Cytidine deaminase. The 2.3 Å crystal structure of an enzyme:transition state analog complex. J. Mol. Biol. 235:1994;635-656.
59. Bransteitter R., et al. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. U. S. A. 100:2003;4102-4107.
60. Chaudhuri J., et al. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature. 422:2003;726-730.
61. Ramiro A.R., et al. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4:2003;452-456.
62. Petersen-Mahrt S.K., Neuberger M.S. In vitro deamination of cytosine to uracil in single-stranded DNA by APOBEC1. J. Biol. Chem. 278:2003;19583-19586.